Premature aging syndrome
MONDO:0019303Changes in the organism associated with senescence, occurring at an accelerated rate.
Also known as: premature ageing, premature aging
109 clinical trials for this condition and its sub-types, 6 tagged with Premature aging syndrome itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Premature aging syndrome
-
Telomere syndrome 9 trials · 92 incl. sub-types
7 sub-types
- Cirrhosis, familial 4 trials · 79 incl. sub-types Sub-types →
- Nodular regenerative hyperplasia of the liver 3 trials
- Immunodeficiency-centromeric instability-facial anomalies syndrome 1 trial Sub-types →
- Pulmonary fibrosis and/or bone marrow failure, telomere-related 1 trial Sub-types →
- ACD-related telomere biology disorder 0 trials Sub-types →
- Coats plus syndrome 0 trials Sub-types →
- Dyskeratosis congenita, autosomal dominant 1 0 trials
-
Progeroid syndrome 3 trials · 11 incl. sub-types
16 sub-types
- Cockayne syndrome 6 trials Sub-types →
- Hutchinson-Gilford progeria syndrome 3 trials
- Werner syndrome 2 trials
- Fischer-Zirnsak progeroid syndrome 0 trials
- Fontaine progeroid syndrome 0 trials
- Garg-Mishra progeroid syndrome 0 trials
- Marbach-Rustad progeroid syndrome 0 trials
- Nestor-Guillermo progeria syndrome 0 trials
- RECON progeroid syndrome 0 trials
- Wiedemann-Rautenstrauch syndrome 0 trials
- XFE progeroid syndrome 0 trials
- Achalasia-progeroid syndrome 0 trials
- Mandibular hypoplasia-deafness-progeroid syndrome 0 trials
- Mandibuloacral dysplasia progeroid syndrome 0 trials
- Progeroid and marfanoid aspect-lipodystrophy syndrome 0 trials
- Progeroid facial appearance with hand anomalies 0 trials
-
Flynn-Aird syndrome 0 trials
-
Acrogeria 0 trials
-
De Barsy syndrome 0 trials
2 sub-types
- ALDH18A1-related de Barsy syndrome 0 trials
- PYCR1-related de Barsy syndrome 0 trials
Most studied deeper sub-types
-
Can cord stem cells rescue a stubborn liver disease?
Disease control Not yet recruitingThis trial tests whether infusions of stem cells from human umbilical cords can help people with primary biliary cholangitis, a liver disease that damages bile ducts. It is for patients who have not responded well to the standard medicine, ursodeoxycholic acid. The study first ch…
Phase 1/2 • Sponsor: Beijing 302 Hospital • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can vaginal estradiol or moisturizer ease menopause symptoms in women with HIV?
Disease control Not yet recruitingThis study compares vaginal estradiol tablets (Vagifem) to a vaginal moisturizer (Replens) for treating menopause-related vaginal and urinary symptoms in women living with HIV. Researchers will also check how these treatments affect the vaginal microbiome. The study includes 62 p…
Phase 4 • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
One pill may tame both itchy skin and stubborn liver disease
Disease control Not yet recruitingThis study tests whether upadacitinib, a drug already approved for eczema, can help people who have both atopic dermatitis (a type of eczema) with moderate to severe itching and a hard-to-treat autoimmune liver disease called cholangitis. The drug works by blocking a pathway invo…
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug seladelpar tracked in Real-Life PBC patients
Disease control Not yet recruitingThis study will follow 100 adults with primary biliary cirrhosis (PBC) who are taking seladelpar in Germany and Switzerland. Researchers will collect real-world data to see if the drug helps improve liver function tests after 48 weeks. The goal is to understand how well seladelpa…
Sponsor: University of Leipzig • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug hopes to stop bone loss in rare aging disease
Disease control Not yet recruitingThis phase 2 trial tests a drug called Progerinin in up to 5 adults with Werner syndrome, a rare condition that causes premature aging and bone loss. Participants take the drug twice daily for about a year. The main goal is to check safety and tolerability, not yet to prove it wo…
Phase 2 • Sponsor: PRG Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New blood test method for liver disease could make diagnosis easier
Diagnosis Not yet recruitingThis study checks if a simpler way to collect blood samples works as well as the standard method for the HepQuant DuO liver test. The test involves drinking a natural substance and taking blood samples 20 and 60 minutes later. Researchers will compare different blood collection t…
Sponsor: HepQuant, LLC • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Could a simple nerve block transform heart surgery recovery?
Symptom relief Not yet recruitingThis study tests whether injecting a local anesthetic near the stellate ganglion in the neck, guided by ultrasound, can improve how patients feel after heart surgery. The block temporarily calms part of the nervous system, which may reduce pain, improve sleep, and lower the risk …
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
New strip drug targets debilitating itch in rare liver disease
Symptom relief Not yet recruitingThis Phase 2a trial tests TH104, a nalmefene strip placed inside the cheek, for moderate to severe itching in primary biliary cholangitis (PBC). About 40 adults with PBC will receive either TH104 or a placebo to see if it safely reduces itch. The study is not yet recruiting.
Phase 2 • Sponsor: Tharimmune Inc • Aim: Symptom relief
Last updated Jun 26, 2026 15:06 UTC
-
Can stem cells from a child with progeria reveal a path to therapy?
Knowledge-focused Not yet recruitingResearchers are taking a blood sample from one child with Hutchinson-Gilford progeria syndrome, a rare condition that causes rapid premature aging. They plan to turn those blood cells into stem cells and then into disease-relevant cells like muscle and nerve cells. This lab model…
Sponsor: Bundang CHA Hospital • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Can we predict who will worsen in PBC? a new study aims to find out
Knowledge-focused Not yet recruitingThis study looks at people with primary biliary cholangitis (PBC), a chronic liver disease that can lead to cirrhosis and liver failure. Researchers will review medical records from hundreds of patients to identify risk factors for faster disease progression. The goal is to build…
Sponsor: Beijing Municipal Administration of Hospitals • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Scientists track everyday exposures to unlock secrets of healthy aging
Knowledge-focused Not yet recruitingThis study investigates how a person's total environment—including lifestyle habits like diet and exercise, social factors, and exposure to pollutants—affects the aging process. Researchers will follow 400 volunteers aged 55 and older from southeastern France, collecting blood sa…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
800-Patient study aims to unlock secrets of autoimmune liver disease
Knowledge-focused Not yet recruitingThis French study will collect medical data and biological samples from 800 people with autoimmune liver diseases. Researchers hope to identify new markers that explain why some patients respond well to treatment while others do not. The goal is to better understand the immune me…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Spleen scan could spare PBC patients unnecessary scopes
Knowledge-focused Not yet recruitingThis study looks at whether measuring spleen stiffness with a simple ultrasound-like test (FibroScan) can help doctors better predict complications in people with Primary Biliary Cholangitis (PBC). Researchers will follow 125 adults already on standard treatment, adding a spleen …
Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC